Jonathan M. Meyer, MD

Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management

August 7, 2023

Next generation therapeutics that work well, are better tolerated, and lead to improved outcomes may offer a different treatment approach for patients with schizophrenia.

Leslie Citrome, Jonathan M. Meyer

Educational Activity

The Glutamate Hypothesis of Schizophrenia

July 15, 2014

Jonathan M. Meyer

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

February 19, 2014

Anissa Abi-Dargham, Jonathan M. Meyer

InfoPacks

How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study

August 15, 2012

Christoph U. Correll, John Lauriello, Ashok Malla, et al

Original Research

The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

December 16, 2009

Jonathan M. Meyer, Lisa C. Rosenblatt, Edward Kim, et al

Educational Activity

Sexual Dysfunction in Patients Treated With Atypical Antipsychotics

September 30, 2008

Jonathan M. Meyer

Article

Antipsychotic Safety and Efficacy Concerns

December 14, 2007

Jonathan M. Meyer

Article

Strategies for the Long-Term Treatment of Schizophrenia: Real-World Lessons From the CATIE Trial

January 15, 2007

Jonathan M. Meyer

Original Research

Prevalence of Hepatitis A, Hepatitis B, and HIV Among Hepatitis C-Seropositive State Hospital Patients: Results From Oregon State Hospital

May 15, 2003

Jonathan M. Meyer

Original Research

A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year

May 12, 2002

Jonathan M. Meyer

Article

Effects of Atypical Antipsychotics on Weight and Serum Lipid Levels

January 14, 2001

Jonathan M. Meyer

Letter to the Editor

Article Commended

March 15, 1998

Edward C. Lauterbach, Jonathan M. Meyer, George M. Simpson

Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management

The Glutamate Hypothesis of Schizophrenia

Schizophrenia: The Role of Dopamine and Glutamate

How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study

The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

Sexual Dysfunction in Patients Treated With Atypical Antipsychotics

Antipsychotic Safety and Efficacy Concerns

Strategies for the Long-Term Treatment of Schizophrenia: Real-World Lessons From the CATIE Trial

Prevalence of Hepatitis A, Hepatitis B, and HIV Among Hepatitis C-Seropositive State Hospital Patients: Results From Oregon State Hospital

A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year

Effects of Atypical Antipsychotics on Weight and Serum Lipid Levels

Article Commended

ELSEWHERE:

FOLLOW US:

Jonathan M. Meyer, MD

Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management

The Glutamate Hypothesis of Schizophrenia

Schizophrenia: The Role of Dopamine and Glutamate

How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study

The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

Sexual Dysfunction in Patients Treated With Atypical Antipsychotics

Antipsychotic Safety and Efficacy Concerns

Strategies for the Long-Term Treatment of Schizophrenia: Real-World Lessons From the CATIE Trial

Prevalence of Hepatitis A, Hepatitis B, and HIV Among Hepatitis C-Seropositive State Hospital Patients: Results From Oregon State Hospital

A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year

Effects of Atypical Antipsychotics on Weight and Serum Lipid Levels

Article Commended

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles